InvestorsHub Logo
Followers 36
Posts 1736
Boards Moderated 0
Alias Born 05/13/2011

Re: vidpok45 post# 1875

Monday, 03/27/2017 8:00:17 AM

Monday, March 27, 2017 8:00:17 AM

Post# of 17574
yes the data that was released at 3:30am today was impressive along with the rest of the studies so far. Voclosporin is a winner and glickman will remain busy fielding early offers and strategies from BP IMO. Its reasonable at this time to assume that the Ph3 trial could be a candidate for early termination due to safety and efficacy so that patients can access this medicine sooner rather than later since there have already been two distinct 48 week data endpt exceeds

GLTA
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AUPH News